image
Merus N.V. MRUS
Healthcare - Biotechnology - NASDAQ - NL
Watchlist
$ 46.58
-6.2 %
$ 3.19 B
Market Cap
-11.56
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 5.68% -18.10% 2.18%
Annual Report FY 10-K 2022-12-31 -15.32% -96.35% -77.87%
Annual Report FY 10-K 2021-12-31 64.00% 21.86% -18.58%
Annual Report FY 10-K 2020-12-31 -3.82% -55.05% -29.36%
Annual Report FY 10-K 2019-12-31 -13.46% -98.66% -32.00%
Annual Report FY 10-K 2018-12-31 141.72% 68.34% 15.08%
Annual Report FY 10-K 2017-12-31 420.44% -76.54% -79.80%
Annual Report FY 10-K 2016-12-31 98.90% -95.96% -15.54%
Annual Report FY 10-K 2015-12-31 52.16% -19.73% -18.91%
Annual Report FY 10-K 2014-12-31 262.03% -54.73% -54.86%
Annual Report FY 10-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 6.70% -334.14% -229.92%
Quarterly Report Q2 8-K 2024-06-30 -30.01% -56.22% -89.98%
Quarterly Report Q1 8-K 2024-03-31 -41.56% 13.30% -27.36%
Quarterly Report Q4 8-K 2023-12-31 -16.19% 26.62% 11.41%
Quarterly Report Q3 8-K 2023-09-30 67.65% 6.51% 54.57%
Quarterly Report Q2 8-K 2023-06-30 -17.41% -460.61% -8.93%
Quarterly Report Q1 8-K 2023-03-31 15.82% -110.35% -35.75%
Quarterly Report Q4 8-K 2022-12-31 -27.49% -468.42% -134.69%
Quarterly Report Q3 8-K 2022-09-30 -51.85% -65.72% -114.01%
Quarterly Report Q2 8-K 2022-06-30 2.46% 79.14% -36.42%
Quarterly Report Q1 8-K 2022-03-31 39.58% -86.06% -24.25%
Quarterly Report Q4 8-K 2021-12-31 63.14% 48.43% -1.58%
Quarterly Report Q3 8-K 2021-09-30 59.50% 35.63% -24.39%
Quarterly Report Q2 8-K 2021-06-30 104.41% -52.38% -45.27%
Quarterly Report Q1 8-K 2021-03-31 32.52% 38.46% -11.35%
Quarterly Report Q4 8-K 2020-12-31 16.66% -6.98% 5.73%
Quarterly Report Q3 8-K 2020-09-30 -4.45% -153.37% -38.92%
Quarterly Report Q2 8-K 2020-06-30 -6.36% -31.86% -22.52%
Quarterly Report Q1 8-K 2020-03-31 -27.15% -136.83% -102.40%
Quarterly Report Q4 8-K 2019-12-31 -20.23% -4032.08% -131.25%
Quarterly Report Q3 8-K 2019-09-30 18.75% 26.68% 6.46%
Quarterly Report Q2 8-K 2019-06-30 -13.00% -156.69% 7.02%
Quarterly Report Q1 8-K 2019-03-31 -28.80% 32.99% -32.57%
Quarterly Report Q4 8-K 2018-12-31 111.64% 96.30% 30.06%
Quarterly Report Q3 8-K 2018-09-30 86.56% 32.67% -14.27%
Quarterly Report Q2 8-K 2018-06-30 101.55% 78.72% -18.52%
Quarterly Report Q1 8-K 2018-03-31 403.89% 54.37% 36.61%
Quarterly Report Q4 8-K 2017-12-31 290.40% 47.05% -24.15%
Quarterly Report Q3 8-K 2017-09-30 304.56% -232.54% -119.09%
Quarterly Report Q2 8-K 2017-06-30 1626.88% -360.21% -113.98%
Quarterly Report Q1 8-K 2017-03-31 3698.56% -268.06% -84.91%
Quarterly Report Q4 8-K 2016-12-31 5467.07% -378.92% -75.50%
Quarterly Report Q3 8-K 2016-09-30 816.88% 19.69% 17.34%
Quarterly Report Q2 8-K 2016-06-30 -82.78% 13.11% 12.77%
Quarterly Report Q1 8-K 2016-03-31 4.66% -18.23% -19.00%
Quarterly Report Q4 8-K 2015-12-31 -95.59% -5.69% -6.42%
Quarterly Report Q3 8-K 2015-09-30 -72.53% -33.84% -30.80%
Quarterly Report Q2 8-K 2015-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2015-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2014-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2014-09-30 0.00% 0.00% 0.00%